Faye Calhoun Named NIAAA Deputy Director
Dr. Faye Calhoun was recently named deputy director of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a component of the National Institutes of Health (NIH).
"Dr. Calhoun brings extensive experience and expertise to her new position," says NIAAA Director Ting-Kai Li, M.D. "I am confident her imaginative and creative leadership will help the Institute address future challenges in alcohol research."
As deputy director, Dr. Calhoun will promote multidisciplinary collaborative research and educational activities in areas of common interest across NIH institutes and centers and with other Federal organizations, including the Substance Abuse and Mental Health Services Administration, the National Highway Traffic Safety Administration, the Department of Justice, and the Department of Education.
Dr. Calhoun joined NIAAA in 1995 as the associate director for NIAAA’s Office of Collaborative Research. She oversaw a broad portfolio of projects that fostered important partnerships between the Institute and other government, non-profit, national, and international organizations. Programs directly under her leadership included the expanded National Alcohol Screening Day, the Alcohol Research Centers and institutional training grants, the alcohol and HIV/AIDS program, international research and training, programs to address health disparities and women’s health issues, and the Interagency Coordinating Committee on Fetal Alcohol Syndrome (ICCFAS).
Prior to joining NIAAA, Dr. Calhoun served as deputy chief for the Referral and Review Branch in the NIH Division of Research Grants (DRG), currently the Center for Scientific Review. At DRG she was responsible for the administration and management of personnel involved in the review of grant applications for research and career development support. Prior to coming to NIH in 1980, she supervised and directed extramural programs for the National Institute on Occupational Safety and Health at the Centers for Disease Control and Prevention, and for the Bureau of Drugs in the Food and Drug Administration (FDA). Her initial appointment at the FDA was as a reproductive toxicologist and pharmacologist.
Dr. Calhoun has been recognized for her outstanding contributions to advancing alcohol research through many distinguished awards, including the NIH Director’s Award and the Research Society on Alcoholism (RSA) Seixas Award for Distinguished Service. She is a member of several professional societies, including the RSA and the Society of Toxicology.
The National Institute on Alcohol Abuse and Alcoholism, a component of the National Institutes of Health, U.S. Department of Health and Human Services, conducts and supports approximately 90 percent of U.S. research on the causes, consequences, prevention, and treatment of alcohol abuse, alcoholism, and alcohol problems and disseminates research findings to science, practitioner, policy making, and general audiences. For additional information on alcohol research and related NIAAA activities, visit www.niaaa.nih.gov.